FibroBiologics Inc
FBLG
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.05M
Close$
$1.11
3.3% downside
Current Fair Value
3.3% downsideOvervalued by 3.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.05 Million |
|---|---|
| Enterprise Value | $-130,912.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.35 |
| Beta | 1.17 |
| Outstanding Shares | 6,272,541 |
Return
| Return on Equity | -391.26% |
|---|---|
| Return on Assets | -228.77% |
| Return on Invested Capital | -313.49% |
Valuation & Multiples
| P/E Ratio | -0.18 |
|---|---|
| PEG | 1.51 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -10.22 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
$-0.93
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
$-0.63
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.88%▼ 0.00% |
|---|---|
| Total Invested | $291,326▼ 70.68% |
| Investors Holding | 17▼ 27.00% |
ESG Score
No data